Get the latest news on Citius Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Citius Pharmaceuticals performance ...
With the business potentially at an important milestone, we thought we'd take a closer look at Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) future prospects. Citius Pharmaceuticals, Inc., a ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
A downtrend has been apparent in Citius Pharmaceuticals, Inc. (CTXR) lately with too much selling pressure. The stock has declined 30.6% over the past four weeks. However, given the fact that it is ...
Hosted on MSN
Maxim Group Downgrades Citius Pharmaceuticals (CTXR)
Fintel reports that on May 23, 2025, Maxim Group downgraded their outlook for Citius Pharmaceuticals (NasdaqCM:CTXR) from Buy to Hold. Analyst Price Forecast Suggests 915.65% Upside As of May 7, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results